BURLINGTON, Mass., Oct. 19,
2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA)
today announced that GENEWIZ Multiomics and Synthesis Solutions
from Azenta Life Sciences will be hosting GENEWIZ Week November 6-10, 2023. The weeklong event will
feature various virtual educational workshops, exclusive
promotions, and a special grant program to recognize excellence in
genomics research.
Throughout the course of the week, the experts in areas
including next generation sequencing (NGS), PCR technologies and
gene synthesis (GS) will be uncovering the many ways genomics is
shaping workflows to go from sample-to-insights and from synthetic
design to biological constructs. Each virtual workshop will be
followed by an interactive roundtable with Azenta experts and guest
speakers.
Each day of GENEWIZ Week will feature a different workshop
topic. Online registration is now open.
Date
|
Time
|
Workshop
Topic
|
Monday, November
6
|
10am & 3pm
EST
|
"Using Sanger to
Complement ONT Whole Plasmid
Sequencing"
|
Tuesday, November 7
|
10am & 3pm
EST
|
"Antibody Sequencing to
Synthesis: An Innovative Workflow
Leveraging Machine Learning to Prioritize Leads"
|
Wednesday, November
8
|
10am & 3pm
EST
|
"Unlocking Lentivirus
Potential: Benefits, Challenges &
Production"
|
Thursday, November 9
|
10am & 3pm
EST
|
"How Does it All Add
Up? Quantitative PCR (qPCR) vs.
Digital PCR (dPCR)"
|
Friday, November
10
|
10am & 3pm
EST
|
"RNA-Seq
Bioinformatics
Workshop"
|
During GENEWIZ Week, the company will recognize excellence in
genomics research through its grant program totaling over
$40,000 in credits, including a
$20,000 grant towards a Proteomics
Olink project. This year, seven winners will be awarded a grant for
use towards a GENEWIZ service, as well as a bonus grant for
consumables. Abstract submissions are due by November 3, 2023 for consideration, and winners
will be announced after GENEWIZ Week concludes.
"We are thrilled to bring back our annual GENEWIZ Week," stated
Ginger Zhou, SVP & General
Manager, GENEWIZ Multiomics and Synthesis Solutions. "This event is
a highlight for the team, and we look forward to a week full of
collaboration and opportunities to engage with our customers."
Visit the website, GENEWIZ Week, for more details as well as the
most up-to-date information.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA)
is a leading provider of life sciences solutions worldwide,
enabling impactful breakthroughs and therapies to market faster.
Azenta provides a full suite of reliable cold-chain sample
management solutions and multiomics services across areas such as
drug development, clinical research and advanced cell therapies for
the industry's top pharmaceutical, biotech, academic and healthcare
institutions globally. Our global team delivers and supports these
products and services through our industry-leading brands,
including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro,
Barkey and B Medical Systems.
Azenta is headquartered in Burlington, MA, with operations
in North America, Europe and Asia. For more
information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-to-host-genewiz-week-november-6-10-2023-301962576.html
SOURCE Azenta